Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic ...

Immune-Onc Therapeutics has dosed the first subject in the Phase Ib/II trial of IO-108 plus Roche’s atezolizumab and ...

Researchers identify a history of GI bleeding and three other factors as elevating variceal bleeding risk in patients ...

Additional Phase 2 data for vilastobart,a tumor-activated, Fc-enhanced anti-CTLA-4, in combination with atezolizumab in patients with MSS CRC ...

An expert discusses how adjuvant therapy options for high-risk muscle-invasive bladder cancer (MIBC); ypT2-ypT4a or N+) ...

Shares of Exelixis (EXEL) are moving lower after the American Society of Clinical Oncology released an abstract on data for zanzalintinib alone or in combination with atezolizumab in patients with ...

A Whakatāne man with terminal cancer says he has outlived his life expectancy after joining a trial for cancer drugs that ...

Relevance section written by JCO Associate Editor Gary K. Schwartz, MD, FASCO. The phase Ib COSMIC-021 study evaluated cabozantinib plus atezolizumab in patients with advanced solid tumors. Presented ...

New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...

One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq ...

Issued on behalf of Oncolytics Biotech Inc. "We're hitting critical milestones that validate our progress and set the stage for what we believe will be an exciting year," said Wayne Pisano, Interim ...

Tiragolumab in combination for untreated advanced non-squamous non-small-cell lung cancer [ID6443] Technology appraisal guidance Tiragolumab with atezolizumab for treating advanced oesophageal ...